Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Onorato

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
European Journal of Internal Medicine|March 9, 2025
Building on the UTILY Study: Exploring uncharted aspects of multidrug-resistant pathogens in urinary tract infections. Author's replyLorenzo Onorato, Margherita Macera, Caterina Monari, et al.
Journal of Medical Virology|April 11, 2020
Prevalence of occult HBV infection in Western countriesMariantonietta Pisaturo, Lorenzo Onorato, Antonio Russo, et al.
Acta Bio-Medica : Atenei Parmensis|May 25, 2019
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysisMariantonietta Pisaturo, Antonio Russo, Lorenzo Onorato, et al.
The Journal of Infection|February 8, 2024
Cefiderocol either in monotherapy or combination versus best available therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections: A systematic review and meta-analysisLorenzo Onorato, Ilaria de Luca, Caterina Monari, et al.
International Journal of Antimicrobial Agents|September 4, 2019
Efficacy of ceftazidime/avibactam in monotherapy or combination therapy against carbapenem-resistant Gram-negative bacteria: A meta-analysisLorenzo Onorato, Giovanni Di Caprio, Simona Signoriello, et al.
World Journal of Clinical Cases|September 19, 2015
Role of genetic polymorphisms in hepatitis C virus chronic infectionNicola Coppola, Mariantonietta Pisaturo, Caterina Sagnelli, et al.
Infection|May 27, 2026
Efficacy of fluoroquinolone prophylaxis in high-risk neutropenic patients with haematological malignancies: a systematic review with meta-analysisLorenzo Onorato, Margherita Macera, Mariagrazia Palamone, et al.
Antibiotics (Basel, Switzerland)|February 25, 2022
Prevalence and Therapeutic Management of Infections by Multi-Drug-Resistant Organisms (MDROs) in Patients with Liver Cirrhosis: A Narrative ReviewLorenzo Onorato, Caterina Monari, Salvatore Capuano, et al.
Journal of Viral Hepatitis|December 14, 2019
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysisMariantonietta Pisaturo, Lorenzo Onorato, Antonio Russo, et al.
Frontiers in Immunology|February 14, 2024
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature dataAntonio Russo, Pierantonio Grimaldi, Mariantonietta Pisaturo, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Internal Medicine|March 9, 2025
Building on the UTILY Study: Exploring uncharted aspects of multidrug-resistant pathogens in urinary tract infections. Author's replyLorenzo Onorato, Margherita Macera, Caterina Monari, et al.
Journal of Medical Virology|April 11, 2020
Prevalence of occult HBV infection in Western countriesMariantonietta Pisaturo, Lorenzo Onorato, Antonio Russo, et al.
Acta Bio-Medica : Atenei Parmensis|May 25, 2019
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysisMariantonietta Pisaturo, Antonio Russo, Lorenzo Onorato, et al.
The Journal of Infection|February 8, 2024
Cefiderocol either in monotherapy or combination versus best available therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections: A systematic review and meta-analysisLorenzo Onorato, Ilaria de Luca, Caterina Monari, et al.
International Journal of Antimicrobial Agents|September 4, 2019
Efficacy of ceftazidime/avibactam in monotherapy or combination therapy against carbapenem-resistant Gram-negative bacteria: A meta-analysisLorenzo Onorato, Giovanni Di Caprio, Simona Signoriello, et al.
World Journal of Clinical Cases|September 19, 2015
Role of genetic polymorphisms in hepatitis C virus chronic infectionNicola Coppola, Mariantonietta Pisaturo, Caterina Sagnelli, et al.
Infection|May 27, 2026
Efficacy of fluoroquinolone prophylaxis in high-risk neutropenic patients with haematological malignancies: a systematic review with meta-analysisLorenzo Onorato, Margherita Macera, Mariagrazia Palamone, et al.
Antibiotics (Basel, Switzerland)|February 25, 2022
Prevalence and Therapeutic Management of Infections by Multi-Drug-Resistant Organisms (MDROs) in Patients with Liver Cirrhosis: A Narrative ReviewLorenzo Onorato, Caterina Monari, Salvatore Capuano, et al.
Journal of Viral Hepatitis|December 14, 2019
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysisMariantonietta Pisaturo, Lorenzo Onorato, Antonio Russo, et al.
Frontiers in Immunology|February 14, 2024
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature dataAntonio Russo, Pierantonio Grimaldi, Mariantonietta Pisaturo, et al.
Pageof 7